Immune Checkpoint Inhibitors (Nivolumab)-Induced Enterocolitis Demonstrated on (18)Fluorine-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography

Nivolumab, an immune checkpoint inhibitor, is a humanized anti-programmed death-1 monoclonal antibody that is used for the treatment of various cancers after second-line chemotherapy. We report a 23-year-old male with relapsed Hodgkin's lymphoma Stage IV treated with nivolumab. After 3 months o...

Descripción completa

Detalles Bibliográficos
Autores principales: Usmani, Sharjeel, Rasheed, Rashid, Marafi, Fahad, Al Kandari, Fareeda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2019
Materias:
Interesting Image
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6481218/
https://www.ncbi.nlm.nih.gov/pubmed/31040539
http://dx.doi.org/10.4103/ijnm.IJNM_141_18

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6481218/
https://www.ncbi.nlm.nih.gov/pubmed/31040539
http://dx.doi.org/10.4103/ijnm.IJNM_141_18

Ejemplares similares